​

Beam Therapeutics (BEAM) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Beam Therapeutics Revenue Highlights

00

Beam Therapeutics Revenue by Period

Beam Therapeutics Revenue by Year

DateRevenueChange
2024-12-31--100.00%
2023-12-31$377.71M520.01%
2022-12-31$60.92M17.51%
2021-12-31$51.84M215916.67%
2020-12-31$24.00K33.33%
2019-12-31$18.00K100.00%
2018-12-31-100.00%
2017-12-31--

Beam Therapeutics generated - in revenue during NA 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Beam Therapeutics Revenue by Quarter

DateRevenueChange
2025-06-30--100.00%
2025-03-31$7.47M-75.16%
2024-12-31$30.07M110.72%
2024-09-30$14.27M21.21%
2024-06-30$11.77M58.87%
2024-03-31$7.41M-97.66%
2023-12-31$316.19M1739.07%
2023-09-30$17.19M-14.53%
2023-06-30$20.12M-16.90%
2023-03-31$24.21M20.82%
2022-12-31$20.04M26.82%
2022-09-30$15.80M-5.12%
2022-06-30$16.65M97.49%
2022-03-31$8.43M-83.49%
2021-12-31$51.07M6593.18%
2021-09-30$763.00K12616.67%
2021-06-30$6.00K-
2021-03-31$6.00K-
2020-12-31$6.00K-
2020-09-30$6.00K-
2020-06-30$6.00K-
2020-03-31$6.00K-
2019-12-31$6.00K-
2019-09-30$6.00K-
2019-06-30$6.00K100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31--

Beam Therapeutics generated - in revenue during Q2 2025, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Beam Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
RAREUltragenyx Pharmaceutical$560.23M$166.50M
GLPGGalapagos$239.70M$62.43M
RXRXRecursion Pharmaceuticals$58.84M$19.22M
IBRXImmunityBio$14.74M$26.43M
IDYAIDEAYA Biosciences$7.00M-
NTLAIntellia Therapeutics-$16.63M
IRONDisc Medicine--
DYNDyne Therapeutics--
BEAMBeam Therapeutics--
DNLIDenali Therapeutics--
BLTEBelite Bio--

BEAM Revenue FAQ

What is Beam Therapeutics’s yearly revenue?

Beam Therapeutics's yearly revenue for 2024 was $0, representing a decrease of -100.00% compared to 2023. The company's yearly revenue for 2023 was $377.71M, representing an increase of 520.01% compared to 2022. BEAM's yearly revenue for 2022 was $60.92M, representing an increase of 17.51% compared to 2021.

What is Beam Therapeutics’s quarterly revenue?

Beam Therapeutics's quarterly revenue for Q2 2025 was $0, a -100.00% decrease from the previous quarter (Q1 2025), and a -100.00% decrease year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $7.47M, a -75.16% decrease from the previous quarter (Q4 2024), and a 0.81% increase year-over-year (Q1 2024). BEAM's quarterly revenue for Q4 2024 was $30.07M, a 110.72% increase from the previous quarter (Q3 2024), and a -90.49% decrease year-over-year (Q4 2023).

What is Beam Therapeutics’s revenue growth rate?

Beam Therapeutics's revenue growth rate for the last 3 years (2022-2024) was -100.00%, and for the last 5 years (2020-2024) was -100.00%.